| CD133 |
Hepatocellular carcinoma, breast cancer |
NCT02541370 |
| CD171 |
Neuroblastoma, ganglioneuroblastoma |
NCT02311621 |
| HER2 |
Gastric cancer, Advanced sarcoma |
NCT01935843 and NCT00902044
|
| CEA |
gastric cancer, pancreatic cancer Colorectal adenocarcinoma |
NCT02349724 and NCT00004178
|
| FAP |
Malignant pleural mesothelioma |
NCT01722149 |
| GD2 |
Neuroblastoma, Ewing's sarcoma, osteosarcoma and melanoma |
NCT01822652 and NCT02107963
|
| MUC1 |
Hepatocellular carcinoma, NSCLC, pancreatic cancer and triple-negative invasive breast cancer |
NCT02617134 and NCT02587689
|
| IL13Rα2 |
Glioma |
NCT02208362 |
| EGFR |
Advanced glioma, EGFR positive solid tumors |
NCT02331693 and NCT01869166
|
| EGFR vIII |
Glioblastoma |
NCT02209376 and NCT01454596
|
| mesothelin |
Pancreatic cancer |
NCT02706782 |
